Zai Lab - About the company
Zai Lab is a public company based in Shanghai (China), founded in 2013 by . It operates as a Developer of drugs for anti-cancer and anti-inflammatory diseases. Zai Lab has raised $160M in funding. The company has 3145 active competitors, including 1094 funded and 747 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Moderna and BeiGene.
Company Details
Developer of drugs for anti-cancer and anti-inflammatory diseases. The company has developed antibody-based therapies for hepatocellular carcinoma and lung cancer. It also develops products to treat asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease, and graft versus host disease.
Key Metrics
Founded Year
2013
Location
Shanghai, China
Stage
Public
Total Funding
in 3 rounds
Latest Funding Round
Investors
Ranked
56th among 3145 active competitors
Annual Revenue
as on Dec 31, 2022
Similar Companies
Exit Details
Public
Legal entities associated with Zai Lab
Zai Lab is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Apr 20, 2017 | $215M (as on Dec 31, 2022) | 473 | 308 |
Get your free copy of Zai Lab's company profile
Zai Lab's funding and investors
Zai Lab has raised a total funding of $160M over 3 rounds. Its first funding round was on Aug 27, 2014. Its latest funding round was a Series C round on Jun 30, 2017 for $30M. 4 investors participated in its latest round, which includes Cormorant Capital, TransPacific Venture Capital Partners, Qiming Venture Partners and Rock Springs Capital.
Zai Lab has 10 institutional investors including Cormorant Capital, and Qiming Venture Partners.
Here is the list of recent funding rounds of Zai Lab:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jun 30, 2017 | $30M | Series C | 7311905 | 2668398 | Orbimed, Vivo Capital, and |
Jan 08, 2016 | $100M | Series B | 3672932 | 2248067 | |
Aug 27, 2014 | $30M | Series A | 4229413 | 9939057 |
Access funding benchmarks and valuations. Sign up today!View details of Zai Lab's funding rounds and investors
Zai Lab's founders and board of directors
The founders of Zai Lab is . is the CEO of Zai Lab.
View details of Zai Lab's Founder profiles and Board Members
Zai Lab's Competitors and alternates
Top competitors of Zai Lab include Jazz Pharmaceuticals, Moderna and BeiGene. Here is the list of Top 10 competitors of Zai Lab, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of therapeutics for cancer and neurological disorders | $265M | Thoma Bravo, Lehman BrothersÌý&²¹³¾±è;Ìý | 86/100 |
2nd |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | Viking Global Investors, Sylvain ZimmerÌý&²¹³¾±è;Ìý | 85/100 |
3rd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | T. Rowe Price, MerckÌý&²¹³¾±è;Ìý | 84/100 |
4th |  Advanced Accelerator Applications 2002, Saint Genis Pouilly (France), Acquired | Novartis company, developing molecular nuclear medicine theranostics | $56.1M | Tamburi Investment Partners, Seventure PartnersÌý&²¹³¾±è;Ìý | 83/100 |
5th | Recursion 2013, United States, Public | R&D based company focused on manufacturing of drugs for multiple therapeutic areas | $452M | Obvious Ventures, Kilmahew VenturesÌý&²¹³¾±è;Ìý | 81/100 |
6th | Incyte 1991, Wilmington (United States), Public | Developer of small molecules for the treatment of different cancer and skin diseases | - | Ridgeback Capital Management, CHL Medical PartnersÌý&²¹³¾±è;Ìý | 78/100 |
7th |  Revolution Medicines 2014, Redwood City (United States), Public | Developer of therapies for treating cancer | $181M | Third Rock Ventures, Colt VenturesÌý&²¹³¾±è;Ìý | 78/100 |
8th | Blueprint Medicines 2008, Cambridge (United States), Public | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | Third Rock Ventures, Ridgeback Capital ManagementÌý&²¹³¾±è;Ìý | 77/100 |
9th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | Delos Capital Partners, Avoro Capital AdvisorsÌý&²¹³¾±è;Ìý | 77/100 |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | Lightchain Capital, The Kraft GroupÌý&²¹³¾±è;Ìý | 76/100 |
56th | 2013, Shanghai (China), Public | Developer of drugs for anti-cancer and anti-inflammatory diseases | $160M | Cormorant Capital, TransPacific Venture Capital PartnersÌý&²¹³¾±è;Ìý | 60/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Zai Lab's competitors? Click to see the top ones
Zai Lab's Investments and acquisitions
Zai Lab has made no investments or acquisitions yet.
Reports related to Zai Lab
Here is the latest report on Zai Lab's sector:
View
News related to Zai Lab
Media has covered Zai Lab for a total of 57 events in the last 1 year, 26 of them have been about company updates and 5 about partnerships.
•
•
MarketBeat•Apr 25, 2025•Zai Lab
•
MarketBeat•Apr 23, 2025•, Zai Lab
•
Business Wire•Apr 23, 2025•Zai Lab
•
Business Wire•Apr 21, 2025•Zai Lab
•
•
Business Wire•Mar 13, 2025•Zai Lab
•
Seeking Alpha•Mar 13, 2025•Zai Lab
•
Seeking Alpha•Feb 27, 2025•Zai Lab
•
Business Wire•Feb 27, 2025•Zai Lab
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Zai Lab
When was Zai Lab founded?
Zai Lab was founded in 2013.Where is Zai Lab located?
Zai Lab is located in Shanghai, China.When was the latest funding round of Zai Lab?
Zai Lab's latest funding round was on Jun 30, 2017.What is the annual revenue of Zai Lab?
Annual revenue of Zai Lab is $215M as on Dec 31, 2022.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- targetNEET - Bengaluru based, 2011 founded, Unfunded company
- Evergreen Agriculture - Abu Dhabi based, 2018 founded, Unfunded company
- Christena B. Imagery - Bedford Heights based, 2018 founded, Unfunded company
- Ace Distribution - Cheyenne based, 2024 founded, Unfunded company
- AngeLend - United States based, 2020 founded, Unfunded company
- Aliot Trade - Bratislava based, 2024 founded, Unfunded company
